Your browser doesn't support javascript.
loading
Reversal of the CD8+ T-Cell Exhaustion Induced by Chronic HIV-1 Infection Through Combined Blockade of the Adenosine and PD-1 Pathways.
Li, Jing; Huang, Hui-Huang; Tu, Bo; Zhou, Ming-Ju; Hu, Wei; Fu, Yu-Long; Li, Xiao-Yu; Yang, Tao; Song, Jin-Wen; Fan, Xing; Jiao, Yan-Mei; Xu, Ruo-Nan; Zhang, Ji-Yuan; Zhou, Chun-Bao; Yuan, Jin-Hong; Zhen, Cheng; Shi, Ming; Wang, Fu-Sheng; Zhang, Chao.
Afiliação
  • Li J; Peking University 302 Clinical Medical School, Beijing, China.
  • Huang HH; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Tu B; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Zhou MJ; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Hu W; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Fu YL; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Li XY; Medical School of Chinese PLA, Beijing, China.
  • Yang T; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Song JW; Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.
  • Fan X; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Jiao YM; Bengbu Medical University, Bengbu, China.
  • Xu RN; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Zhang JY; Medical School of Chinese PLA, Beijing, China.
  • Zhou CB; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Yuan JH; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Zhen C; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Shi M; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Wang FS; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Zhang C; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
Front Immunol ; 12: 687296, 2021.
Article em En | MEDLINE | ID: mdl-34177939

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apirase / Infecções por HIV / Adenosina / HIV-1 / Linfócitos T CD8-Positivos / Fármacos Anti-HIV / Inibidores Enzimáticos / Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apirase / Infecções por HIV / Adenosina / HIV-1 / Linfócitos T CD8-Positivos / Fármacos Anti-HIV / Inibidores Enzimáticos / Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article